Gilead Sciences (GILD)
(Real Time Quote from BATS)
$64.70 USD
-0.55 (-0.84%)
Updated Jun 11, 2024 02:30 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 381 - 400 ( 525 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 28
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Zacks Earning Trends: What to Look for This Earnings Season, companies mentioned- AAPL, BAC, GILD
Provider: ZACKS INVESTMENT RESEARCH
Analyst: MIAN S
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Zacks Earning Trends: 3 Things to Know About Q1 Earnings Season, companies mentioned- FDX, ADBE, CTAS, GILD
Provider: ZACKS INVESTMENT RESEARCH
Analyst: MIAN S
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended March 6
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Feb 27
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Jan 9
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Jan 2
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended Dec 12
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Dec 5
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology/Biopharmaceuticals/BioDefense-Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Nov 14
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended August 29
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Zacks Earning Trends: Q2 Earnings Season in Rearview Mirror, companies mentioned- WMT, TGT, M, GILD, VZ.
Provider: ZACKS INVESTMENT RESEARCH
Analyst: MIAN S